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Clinicopathological significance of intratubular giant macrophages in
progressive glomerulonephritis. Very large macrophages, which we have
termed “giant macrophages” (G-Mf), have been found in renal tubules,
some containing cytoplasmic vacuoles. To elucidate their pathophysiolog-
ical roles, we examined renal biopsy tissues from various primary glomer-
ulonephritis (GN) and tubulointerstitial nephritis (TIN) using immuno-
histochemistry with monoclonal antibodies against Mf and other cell
surface markers. Giant macrophages were absent or rare in TIN, minimal
change nephrotic syndrome, and minor glomerular abnormalities, but
G-Mf was plentiful in progressive glomerulonephrides such as IgA
nephropathy with crescents, membranoproliferative GN, focal segmental
glomerulosclerosis, and especially in crescentic GN. These G-Mf were
usually seen in the lumen of renal tubules, but occasionally were found in
the Bowman’s spaces and glomerular tufts, and similar cells were also
found in urine. Moreover, they frequently made contact with tubular
epithelial cells expressing intercellular adhesion molecule-1, and the
tubular epithelial cells in such lesions often had degenerative changes.
Giant Mf may damage tubular epithelial cells from the luminal side.
Phenotypically, G-Mf showed activated (CD711) and mature (25F91)
characteristics along with features of Mf (CD681), and the cytoplasm
contained a great deal of lipids. The numbers of G-Mf in renal tissues
closely correlated with the degree of hematuria (r 5 0.5, P , 0.001),
serum creatinine value (r 5 0.63, P , 0.001) in GN patients (N 5 96) and
with proteinuria in IgA nephropathy patients (r 5 0.89, P , 0.001, N 5
27). These data suggest that G-Mf are Mf that were activated and
matured in certain active inflammatory sites, which flowed into tubules
and then into urine. Thus, the existence of G-Mf in biopsy tissue or urine
reflect the activity of GN and may have a predictive value for the
progression of GN.
Glomerular or interstitial macrophages (Mf) have often been
mentioned in the literature as mediating renal tissue damage in
glomerulonephritis (GN) and tubulointerstitial nephritis (TIN)
[1–4]. In particular, recent studies emphasize that tubular inter-
cellular adhesion molecule-1 (ICAM-1) expression induces tubu-
lar damage via the interaction of epithelial cells (which may have
an antigen presenting ability) with infiltrating effector cells
through an ICAM-1 related adhesion [5–8]. However, this notion
is somewhat questionable because ICAM-1 expression on the
tubular epithelium is more prominent on the luminal rather than
the basilar side of the tubules [6, 9], while interstitial infiltrating
cells must make contact from the basilar side of the epithelium.
Some intratubular infiltrating cells appear to be different. They
are exceptionally large and contain cytoplasmic vacuoles, and they
often make contact with ICAM-1 positive tubular epithelium from
the luminal side. We termed these novel intratubular infiltrating
cells “giant Mf” (G-Mf), and examined their phenotypic char-
acteristics and the correlations between their occurrence and
clinical or histological manifestations in various types of GN. Here
we demonstrate that these cells differ phenotypically from exfo-
liated tubular epithelial cells, but are similar to cells of the Mf
lineage. They show activated and mature characteristics and have
high scavenging ability, probably because of macrophage scaven-
ger receptor (SR) expression. The occurrence of these cells is
significantly higher in progressive GN patients, especially those
with crescents, and is closely correlated with certain clinical data
on GN patients, such as the degree of hematuria, serum creatinine
value, and proteinuria. Similar cells can also be found in urine.
In the present study, we propose that the existence of these cells
in biopsy tissues reflects the activity of GN and may have a
predictive value for GN progression, and that G-Mf may damage
tubular epithelial cells from the luminal side. We also discuss the
mechanism underlying their appearance in renal tissues.
METHODS
Patients
Renal tissues were obtained for diagnostic purposes by surgical
needle biopsy from 96 patients with various primary GN. Of the
96 patients, 11 showed minor glomerular abnormalities (MGA,
confirmed as isolated C3 deposition disease by immunofluores-
cence examination), 7 had minimal change nephrotic syndrome
(MCNS), 11 had focal segmental glomerulosclerosis (FGS), 16
had membranous nephropathy (MN), 8 had membranoprolifera-
tive GN (MPGN), 27 had IgA nephropathy (IgAN), and 16
showed crescentic rapidly progressive GN (RPGN, defined as
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crescents in .60% of glomeruli). An additional 11 patients with
tubulointerstitial nephritis (TIN) were also included in this study.
The diagnosis of GN or TIN was based on typical clinical
symptoms and laboratory data along with the characteristic histo-
logical features of the renal tissue by light and electron micro-
scopic and direct immunofluorescent studies.
Monoclonal and polyclonal antibodies
Details on 14 monoclonal antibodies (mAb) and 1 polyclonal
antibody used as the primary antibodies for immunohistochemical
analysis are listed in Table 1. We used anti-CD 68 (PG-M1 and
EBM-11) mAb for the detection of Mf (PG-M1 for paraffin
sections, EBM-11 for frozen sections) and 25F9 mAb to identify
mature Mf [10]. We also used CD3, CD4, CD8 and CD45RO as
T cell markers, CD20 as a marker for B cells, and pan cytokeratin
(KL1) as an epithelial cell marker. HLA-DR and CD16 were used
as activation markers [11], and CD71 (a transferrin receptor) was
used as both activation [12] and maturation [13] markers of Mf.
ICAM-1 and leukocyte function associated-1 (LFA-1) were used
to investigate the cell to cell interaction. Ki-67 polyclonal antibody
was used as a marker for cell proliferation; Ki-67 is an “Enhanced
Polymer One-Step Staining” (EPOS; DAKO, Copenhagen, Den-
mark) reagent that is formed by antibody and horseradish perox-
idase coupled to an inert polymer backbone [14].
Histological staining
Immunohistochemical staining was accomplished by the biotin-
streptavidin-peroxidase method, using a DAKO LSAB kit
(DAKO). Briefly, the endogenous peroxidase activity in deparaf-
finized formalin fixed tissue sections or periodate lysine parafor-
maldehyde (PLP) fixed frozen tissue sections was blocked by
incubating for 10 minutes in 3% H2O2 in distilled water. After
incubation with 10% fetal calf serum (FCS) in phosphate buffered
saline (PBS), the sections were allowed to react with appropriate
dilutions of the primary antibodies for 40 minutes. Thereafter the
sections were incubated with biotinylated rabbit anti-mouse IgG
as the second antibody for 30 minutes, followed by incubation
with peroxidase-conjugated streptavidin for 20 minutes. Color
reaction of peroxidase was performed in a solution of 0.02%
3,39-diaminobenzidine (DAB) and 0.005% H2O2 in 50 mmol/liter
Tris (pH 7.6). Finally, the sections were generally counterstained
with methyl green, but in some patients PAS counterstaining was
performed in order to more precisely localize the immunoreactive
cells. All incubations were performed at room temperature. The
specificity of labeling was confirmed by the absence of staining by
substitution of PBS for the primary antibody. Moreover, double
staining for CD68 and cytokeratin was performed to more pre-
cisely differentiate between the Mf and tubular epithelial cells.
CD68 was stained by the biotin-streptavidin-peroxidase method
and developed with 3-amino-9-ethylcarbazole (AEC) (red). This
was followed by an indirect immuno-alkaline phosphatase staining
procedure, consisting of three washings in PBS, after which the
sections were allowed to react with KL-1 (mAb against cytoker-
atin) for two hours. Thereafter, they were incubated for one hour
with alkaline phosphatase-conjugated rabbit anti-mouse IgG
(DAKO). The coloration of alkaline phosphatase was carried out
using the technique described by Cordell et al [15]. When
naphthol AS-BI-phosphate and Fast Blue BB salt were used as a
substrate, the reaction products were dark blue. To assess the
proliferation ability, double staining for Ki-67 and CD68 was
performed as described [16], by carrying out EPOS staining
(recently developed, highly sensitive modified direct immunoper-
oxidase staining) for Ki-67 and indirect immunoperoxidase stain-
ing for CD68 sequentially. EPOS was developed with DAB
enhanced with NiCl2 (dark brown) and the next immunoperoxi-
dase was developed with AEC (red).
In addition to immunohistochemistry, we used enzyme-histo-
chemistry, that is, nonspecific esterase (NSE) and chloroesterase
(CHE) staining to detect Mf and neutrophils, respectively. Pro-
cedures for these techniques are described by Li et al [17]. As
substrate, a-naphthyl butylate and Fast Garnet GBC were used
for the NSE staining (red reactive products), and naphthol AS-D
chloroacetate and Fast Blue BB salt were used for the CHE
staining (blue reactive products). To assess the cytoplasmic dep-
osition of lipid, we adapted oil red O staining on the cryostat
sections of biopsy specimens, according to the procedure de-
scribed by Brown et al [18].
Table 1. Antibodies used in this study
Cluster no. Antibody Specificity Source
Working
dilution
CD68 PG-M1 monocyte/macrophage DAKO 1:100
CD68 EBM-11 monocyte/macrophage DAKO 1:100
25F9 mature macrophage BMA 1:25
CD3 Leu4 pan T Becton Dickinson 1:100
CD4 Leu3a T helper/inducer Becton Dickinson 1:100
CD8 Leu2a T suppressor/cytotoxic Becton Dickinson 1:1
CD45RO UCHL-1 memory T DAKO 1:50
CD20 L26 pan B DAKO 1:1
KL1 pan cytokeratin IMMUNOTECH 1:200
HLA-DR activated T, B, M f DAKO 1:100
CD71 NU-TfR1 transferrin receptor Nichirei 1:30
CD16 Leu11 NK, activated M f Becton Dickinson 1:20
CD11a LFA-1 leukocytes DAKO 1:100
CD54 84H10 ICAM-1 IMMUNOTECH 1:400
Ki-67 proliferating cells DAKO 1:1
Oda et al: Intratubular giant Mf in glomerulonephritis 1191
Quantification
The degree of G-Mf infiltration was semiquantitatively as-
sessed on the tissue sections stained by anti-CD68 mAb in GN and
TIN under the light microscope. The total number of G-Mf
(CD681 cells whose sizes are almost equal to or greater than
tubular epithelial cells) in tubules of renal cortex in each biopsy
specimen was divided by the total number of tubules in the renal
cortex and expressed in terms of the number of intratubular
G-Mf per 100 tubules.
Immuno- and enzyme-cytochemical analysis of urinary
sediments
Urinary sediments from five RPGN patients were obtained by
centrifugation for 10 min at 1500 rpm and washed in PBS. After
eliminating red blood cells by hypotonic lysis, the sediments were
resuspended in PBS at a concentration of 1 3 106 cells/ml. The
cells in 0.1 ml suspensions were deposited onto a microscope slide
by centrifugal force (500 rpm, 5 min) using a Cytospin 3 (Shandon
Scientific Limited, Cheshire, UK). Thereafter the slides were air
dried for 15 minutes and fixed by 4% paraformaldehyde (PFA) in
PBS for five minutes. NSE and CHE were simultaneously local-
ized on these slides (as described above) to investigate the Mf
and neutrophils in the urinary sediments. To rule out the cross
reactivity of NSE with epithelial cells, we performed triple stain-
ing for CHE (neutrophils), CD68 (Mf), and cytokeratin (epithe-
lial cells). After CHE staining (blue), the biotin-streptavidin-
peroxidase method for immunolocalization of CD68 (developed
with DAB: brown) and cytokeratin (developed with AEC: red),
was applied sequentially.
Detection of macrophage scavenger receptor mRNA in biopsy
tissue and urinary sediments
Abundant deposition of lipid in the cytoplasm of G-Mf indi-
cates the up-regulation of macrophage scavenger receptor (SR)
expression on this cell. SR mRNA in the total RNA isolated from
urinary sediments and renal biopsy tissues of IgAN without
crescents (which have little or no G-Mf infiltration), IgAN with
crescents and RPGN (which have prominent G-Mf infiltration),
was investigated by reverse transcription-polymerase chain reac-
tion (RT-PCR). Total RNA was isolated using a reagent for single
step isolation of RNA: ISOGEN (Nippon Gene, Toyama, Japan)
[19]. RNA concentration and purity were determined by spectro-
photometer (Shimazu Corp., Kyoto, Japan) at 260 and 280 nm. A
0.2 mg or 1 mg portion of the total RNA from urinary sediments
or renal biopsy tissues, respectively, was reverse transcribed in a
reaction volume of 20 m1 using a first strand cDNA synthesis kit
(Boehringer Mannheim Corp., Mannheim, Germany), which in-
cluded avian myeloblastoma virus reverse transcriptase and ran-
dom primer. PCR was performed using an Expand™ high fidelity
PCR system (Boehringer Mannheim) with SR specific synthetic
primer sets: one 59 primer that locates on the domain IV
(a-helical coiled coil) of SR, which is common to SR type I and II,
and both type I-specific and type II-specific 39 primers, whose
sequences have been described by Ando et al [20]. The predicted
size of amplified product for SR type I was 451 bp and for SR type
II was 295 bp in length.
One microliter of cDNA, representing 10 ng or 50 ng of the
original RNA from urinary sediments or renal tissues, respec-
tively, was applied as template for PCR. The final concentrations
of the PCR reaction mixture were 0.3 mM of 59 primer, 0.15 mM of
each 39 primer, 200 mM of each dNTPs, 2.6 U Expand™ high
fidelity polymerase mix, and buffer, as recommended by the
supplier (Boehringer Mannheim), in a volume of 50 ml. The tubes
were then placed in a DNA thermal cycler (Sanko Junyaku Co.,
Ltd, Tokyo, Japan) that was programmed so that the first incu-
bation was performed at 94°C for 5 minutes. This was followed by
35 cycles consisting of the following steps: 94°C for 1 minute
(melt); 55°C for 1 minute (anneal); 72°C for 1 minute (extension).
Last was an incubation at 72°C for 7 minutes (final extension).
The samples were kept at 4°C until the time of analysis. Glycer-
aldehyde-3-phosphate dehydrogenase (GAPDH) mRNA was de-
tected similarly by RT-PCR using GAPDH specific synthetic
primers whose sequence was described by Lipman, Stevens and
Strom [21], to evaluate the PCR efficiency and the amount of
template RNA. The predicted size of amplified product was 496
bp in length.
Nine microliters of PCR products were electrophoresed on 3%
agarose gels with size marker (100 Base-Pair Ladder, Pharmacia
Biotech, AB, Uppsala, Sweden) and visualized by ethidium bro-
mide staining and ultraviolet transillumination.
Statistical analysis
Data are expressed as mean 6 SD, and statistical significance
was analyzed by Student’s t-test. Correlations were assessed by
Pearson’s product moment correlation or Spearman’s rank corre-
lation test. Differences were considered significant if P # 0.05.
RESULTS
Histological and phenotypic characteristics of giant
macrophages
Many large isolated cells were found in the lumen of renal
tubules adjacent to glomeruli that had small crescent (Fig. 1A).
These cells resembled exfoliated tubular epithelial cells, but in
sequential section they showed strong immunoreactivity for CD68
(Fig. 1B), which is not usually expressed on the tubular epithelial
cells. Interestingly, these intratubular giant cells often made
contact with tubular epithelial cells, and tubular epithelial cells
with giant cell adhesions often had cytoplasmic vacuoles or
hyaline droplet degenerative changes (Fig. 1 C, D). The giant cells
were generally seen in the lumen of renal tubules but were
occasionally found in glomerular Bowman’s spaces (Fig. 2 A, B)
and flowing into tubular lumen (Fig. 2C, arrowheads); they were
also found in glomerular tufts, however, they were quite rare (Fig.
2B, arrowheads). Generally, glomerular intra-tuft CD681 cells
were not giant (Fig. 2A, arrows), but seemed to become ovoid-
shaped giant cells at the Bowman’s space level. In some patients
the giant cells were sometimes found lining Bowman’s capsules of
some glomeruli or lining some tubular basement membranes
(TBM; Fig. 2D). Light and electron microscopic observation
revealed that the giant cells were extraordinarily large, contained
cytoplasmic vacuoles of various sizes (Fig. 2E), and were usually
filled with lipid (as shown by oil red O staining; Fig. 2F). The giant
cells showed various characteristic features of Mf (such as,
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strongly positive for CD68, NSE, and weakly positive for CD4
[22]) but were negative for T cell (CD3, CD45RO), B cell (CD20),
or neutrophil (CHE) markers. Moreover, by double immunostain-
ing, these cells were completely negative for cytokeratin, which is
usually expressed in tubular epithelial cells (Fig. 4A). Phenotyp-
ically, the giant cells were mature (25F9 and CD71 positive, Fig.
3 A, C), and activated (HLA-DR and CD71 positive, Fig. 3 B, C),
although the cytotoxic activation marker (CD16) [11] was nega-
tive. Results of the immunoreactivity and enzyme activity of
G-Mf are summarized in Table 2. To further assess the interac-
tion of these cells with tubular epithelial cells, CD68 (developed
with DAB enhanced with NiCl2: dark brown) and ICAM-1
(developed with AEC: red) were stained simultaneously. This
demonstrated the frequent contact of CD681 G-Mf (which is
also strongly positive for LFA-1) with ICAM-11 tubular epithelial
cells on the luminal surface (Fig. 4B). Double staining for Ki-67
and CD68 revealed that double positive cells really existed, but
the labeling index of Ki-67 in CD681 G-Mf was very low (less
than 2.0%; Fig. 4 C, D).
Correlation with histological and clinical manifestations
Few if any G-Mf were found in the TIN, MGA or MCNS cases.
Several IgAN and MN cases showed prominent G-Mf infiltra-
tion, but the mean numbers were not enough to differ significantly
from that in MGA (Fig. 5A). In particular, most IgAN patients
with prominent G-Mf infiltration had glomerular crescents, while
all MN patients with prominent G-Mf infiltration had glomerular
segmental sclerosis. Significantly (P , 0.05) higher levels of
intratubular G-Mf infiltration were found in the FGS, MPGN
and RPGN cases. Since intratubular G-Mf were especially abun-
dant (P , 0.01) in all RPGN patients, we suspected that the
existence of glomerular crescent was relevant to the G-Mf
infiltration. In fact, the G-Mf numbers were significantly higher
in GN patients with crescents (39 patients: 16 IgAN, 7 MPGN, 16
RPGN) than in those without crescents (57 patients: 11 MGA, 7
MCNS, 11 FGS, 16 MN, 1 MPGN, 11 IgAN; 6.3 6 9.7 vs. 0.2 6
0.5, P , 0.001; Fig. 5B). With regards to the clinical data,
Fig. 1. Representative serial sections of PAS (A) and CD68 immunoperoxidase staining (B) in a case of IgA nephropathy (IgAN). Note prominent
infiltration of enlarged cells in the tubules adjacent to the glomeruli which has small crescent (A). These cells are positive for macrophage marker CD68
(B) and were termed “giant macrophages” (G-Mf). (C and D) Representative light microscopic view of PAS stained sections. Note the attachment of
intratubular giant cells to tubular epithelial cells (arrows); such tubular epithelial cells often have cytoplasmic vacuoles (C) or hyaline droplet
degenerative changes (D) (magnifications: A, B, 3630; C, 31250; D, 31900).
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significant correlations between G-Mf counts with serum creati-
nine levels (r 5 0.63, P , 0.001; Fig. 6A) and with the degree of
urinary RBC (r 5 0.5, P , 0.001 by Spearman’s rank correlation
test; Fig. 6B) were observed in GN patients (N 5 96). Among all
GN patients, there was no significant correlation between levels of
proteinuria and G-Mf counts, whereas the correlation was signif-
icant in IgAN patients considered separately (N 5 27, r 5 0.89,
P , 0.001; Fig. 6C).
Fig. 2. Representative immunoperoxidase staining for CD68 with PAS counterstaining in tissues from rapidly progressive glomerulonephritis (RPGN)
patients. Giant macrophages (G-Mf) were usually found in the lumen of tubules, but occasionally in Bowmann’s spaces (A, B), and rarely glomerular
tufts (B, arrowheads) and flowing into tubular lumen (C; arrowheads). In most cases, glomerular intra-tuft CD681 cells were small (A, arrows), but
seemed to become quite large at the Bowmann’s space level. In some patients, the giant cells were also found lining Bowman’s capsules or lining tubular
basement membrane (TBM) (D). Note the obvious difference in size between intratubular or intraglomerular G-Mf and interstitial infiltrating Mf. (E,
F) Representative electron micrograph and oil red O staining of a biopsy tissue from a membranoproliferative glomerulonephritis (MPGN) patient with
crescents. G-Mf have vacuoles of various sizes (E), and contain a lot of lipid in the cytoplasm (F) (magnifications: A–C, 3810; D, 31620; E, 315000;
F, 32450).
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Excretion of giant macrophages in urine
Double and triple staining of urinary sediment specimens from
RPGN patients clearly demonstrated the existence of many cells
similar to G-Mf in biopsy tissue. These cells were clearly larger
than neutrophils, often had cytoplasmic vacuoles, and were
strongly positive for NSE (Fig. 7A), CD68 (Fig. 7B), 25F9, and oil
red O staining (data not shown), but negative for cytokeratin (Fig.
7B).
Macrophage scavenger receptor mRNA expression in urine and
tissues
By RT-PCR, no bands or at best weak bands were observed in
the total RNA isolated from both urinary sediments (Fig. 8A) and
renal biopsy tissues (Fig. 8B) of IgAN patients without crescents
(Lanes 1 to 3), but distinct bands were observed at the predicted
size of both SR type I and II in IgAN patients with crescents
(Lanes 4 to 6) and RPGN patients (Lane 7 to 9).
DISCUSSION
In this study, we investigated various cases of primary GN with
special attention to a novel giant intratubular infiltrating cell
(G-Mf). Although these cells morphologically resemble exfoli-
ated tubular epithelial cells both in size and shape, phenotypically
they differ from tubular epithelium but are similar to cells of
monocyte/Mf lineage. However, they differ from the usual inter-
stitial infiltrating Mf in both histological (they are obviously
bigger than interstitial infiltrating Mf) and phenotypic characters
(they are all positive for 25F9 while most interstitial infiltrating
Mf are not).
Macrophages are classified into several subsets according to the
status of cell activation and differentiation [10–13]. Antibody
Fig. 3. Representative immunoperoxidase staining for mature macro-
phage (Mf) marker (25F9) (A), HLA-DR (B), and transferrin receptor
(CD71) (C) in biopsy specimens from rapidly progressive glomerulone-
phritis (RPGN) patients. Note the strong cytoplasmic positivity of 25F9
and cell surface positivity of HLA-DR and CD71 on G-Mf (magnifica-
tions: A, 31250; B, 3940; C, 31900).
Table 2. Immunoreactivity and enzyme activity of giant macrophages
(G-Mf)
CD68 (monocyte/macrophage) 111
25F9 (mature macrophage) 111
CD3 (pan T) 2
CD4 (T helper/inducer) 1
CD8 (T suppressor/cytotoxic) 2
CD45RO (memory T) 2
CD20 (pan B) 2
KL1 (pan cytokeratin) 2
HLA-DR 111
CD71 (transferrin receptor) 11
CD16 2
CD11 (LFA-1) 111
CD54 (ICAM-1) 1
NSE (macrophage) 111
CHE (neutrophil) 2
Staining intensity was graded under light microscopy as: 2, negative; 1
positive for occasional cells; 11, positive for most cells; 111 strongly
positive for all cells.
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25F9, which was used in this study and recognizes the 86 kDa
protein on human Mf, is one of several tools available for
evaluating Mf subsets. It is known to be absent on peripheral
leukocytes, including monocytes, but is expressed on mature,
noninflammatory Mf in various tissues such as the Kupffer cells
of the liver, alveolar Mf, and thymus Mf [10]. CD71 and
HLA-DR are also some of the useful markers for the functional
activation [11, 12] and maturation [13] of Mf. Interestingly,
different stimuli are known to induce up-regulation of Mf surface
markers and morphological differentiation in different manners.
For example, Mf matured by cultivation in the presence of
M-CSF are morphologically elongated and spindle-shaped and
many of them express CD16, while those matured in the presence
of GM-CSF or interleukin (IL)-3 are morphologically large round
cells with distinct nuclei and rarely express CD16. However, the
three cytokines induce similar levels of HLA-DR expression.
Further, all Mf supported by these cytokines develop a capacity
for both antibody-dependent and -independent cellular cytotoxity,
but the cytotoxity level is greatest in M-CSF treated Mf and is
correlated with CD16 expression [11]. In this sense, G-Mf
resemble Mf matured in the presence of GM-CSF or IL-3.
Macrophage scavenger receptor (SR) is also known to be ex-
pressed on Mf with cell maturation and with cell differentiation
induced by certain cytokines, such as M-CSF and GM-CSF, and
they up-regulate the scavenging ability of Mf [23–25]. We could
not directly examine SR protein expression of G-Mf in the
present study because we could not obtain a specific antibody
against human SR. However, it seems likely that the cells in the
present study were in an activated (CD711, HLA-DR1) and
mature (25F91, CD711) condition and were actively involved in
scavenging, as judged from cytoplasmic deposition of abundant
quantities of lipid. Moreover, prominent up-regulation of the SR
Fig. 5. A. Intratubular giant macrophages (G-
Mf) in various primary glomerulonephritis
(GN) and in tubulointerstitial nephritis (TIN).
Few if any G-Mf are found in TIN, minimal
change nephrotic syndrome (MCNS) or in
those with minor glomerular abnormalities
(MGA). The G-Mf number is significantly
higher in focal segmental glomerulosclerosis
(FGS), MPGN, and RPGN than in MGA. In
membranous nephropathy (MN) and IgAN, the
mean G-Mf number appears higher than in
MGA, but the difference is not statistically
significant (*P , 0.05, **P , 0.01 vs. MGA).
(B) GN patients were divided into two groups
on the basis of the presence or absence of
glomerular crescents (crescent1, 39 patients;
crescent2, 57 patients). The G-Mf number is
significantly higher in the crescent1 group than
in the crescent2 group (6.3 6 9.7 vs. 0.2 6 0.5,
P , 0.001).
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mRNA found in the biopsy tissues and in urinary sediments of
those patients with glomerular crescents and prominent G-Mf
infiltration suggest that G-Mf must express SR on their cell
surface. Immunoreactivity for Ki-67 showed that G-Mf have the
ability to proliferate, but the level is very low (lower than that
reported on resident Mf [26]), which supports the mature
character of this cell.
With regard to the source of G-Mf, a glomerular origin is
suggested because they are found in Bowman’s capsules and
glomerular tufts and are not found in the interstitium, even in
cases of TIN. The phenotypic characters of G-Mf found in
glomeruli and in tubules are essentially identical. Moreover, the
significant relationship between G-Mf infiltration and the exis-
tence of glomerular crescents indicates that they derive from cells
that form a part of crescents. However, there were some cases that
showed G-Mf infiltration without glomerular crescents, especially
in FGS and MN. Two possible explanations come to mind: (1)
crescents actually existed but were not observed in the biopsy
tissues or sections because of the limitation of renal biopsy
specimens [27]; (2) some mechanisms other than (or in addition
to) crescents may account for G-Mf formation. Actually, all MN
and FGS patients with G-Mf infiltration in this study had
segmental sclerosis, notwithstanding the absence of crescents in
the biopsy specimen. Recent studies indicate that progression of
MN is often accompanied by development of glomerular focal
segmental sclerotic lesions similar to those of idiopathic FGS [28].
Moreover, it has been reported that Mf infiltrate in the glomeruli
and play an important role in the development of FGS [29]. Thus,
segmental sclerosis is also believed to contribute to the appear-
ance of G-Mf in such patients.
Given the findings on the phenotypic characteristics and origins
of G-Mf, we may now tentatively outline a mechanism underlying
the appearance of G-Mf. Bone marrow-derived monocyte/Mf
accumulate in active inflammatory lesions of glomeruli, where
they are activated and matured by certain inflammatory cytokines.
GM-CSF is one of the most probable candidates because of the
morphologic and phenotypic character (including SR expression)
of G-Mf, as mentioned earlier, and because it is known to be
produced by mesangial cells [30]. They then increase in size and
scavenging ability by the up-regulation of SR expression, change
to G-Mf, and flow into tubules through GBM breaks at the site
and then into urine. Thus, the appearance of G-Mf in renal tissue
indicates the presence of active inflammatory sites in glomeruli,
especially crescents. The number of glomeruli that can be ob-
served in a single biopsy tissue section is usually limited [27].
Tubules in biopsy specimens, however, are more abundant, and by
assessing intratubular G-Mf numbers we can derive more infor-
mation about the glomerular lesions from the biopsy specimen.
Alternatively, we suspect the possibility that glomerular parietal
or visceral epithelial cells or tubular epithelial cells change their
Fig. 6. A. Correlation between serum creatinine (SCr) levels and intratu-
bular giant macrophages (G-Mf) number in glomerulonephritis (GN)
patients (r 5 0.63, P , 0.001, N 5 96). (B) G-Mf numbers in each GN
patient are plotted in relation to the urinary red blood cell (RBC) levels.
The correlation is significant (r 5 0.5, P , 0.001, N 5 96, Spearman’s rank
correlation test). (C) Correlation between proteinuria levels and intratu-
bular G-Mf number in IgAN patients (r 5 0.89, P , 0.001, N 5 27). The
correlation is not significant when all GN patients are included.
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Fig. 4. A. Double staining for CD68 (immunoperoxidase-AEC: red) and cytokeratin (immuno-alkaline phosphatase: dark blue) in a biopsy specimen
from a rapidly progressive glomerulonephritis (RPGN) patient. CD68 and cytokeratin are expressed on different cells, that is, cytokeratin is completely
negative on G-Mf. (B) Triple staining for CD68 (immunoperoxidase-DAB NiCl2: dark brown), ICAM-1 (immunoperoxidase-AEC: red) and
chroloesterase (CHE: blue) in a biopsy specimen from a mesangioproliferative glomerulonephritis (MPGN) patient with crescents. Note the frequent
touch of CD68-positive G-Mf with ICAM-1-positive tubular epithelial cells (arrows). (C and D) Double staining for Ki-67 (immunoperoxidase-DAB
NiCl2: dark brown), and CD68 (immunoperoxidase-AEC: red) in a biopsy specimen from an RPGN patient. Double positive cells were found (D is
higher power view of the arrowed cell in C), but the labeling index of Ki-67 on CD681 G-Mf was very low (lower than 2.0%) (magnifications: A and
B, 31620; C, 3810; D, 31620).
Fig. 7. A. Double staining for CHE (neutrophil, blue) and nonspecific esterase (NSE: Mf, red) in urinary sediments of an RPGN patient. Note the
two types of NSE positive cells: one is smaller (arrowhead, ordinary monocyte/Mf), and another is larger than neutrophils (arrow, probably the same
as G-Mf in renal tubules). (B) Triple staining for CD68 (immunoperoxidase-DAB: brown), cytokeratin (immunoperoxidase-AEC: red) and CHE (blue)
in urinary sediments of an RPGN patient. Most cells are CD68-positive G-Mf (arrowheads), and several epithelial cells and neutrophils are
intermingled (magnifications: A, 32450; B, 31620).
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phenotype to express Mf markers and exfoliate to flow into
tubular lumen, because it is difficult to explain the appearance of
G-Mf lining Bowman’s capsule or TBM (Fig. 2D) by solely
extrinsic cellular infiltration. Further, in FGS and MN, glomerular
Mf locate in endocapillary sites and GBM breaks are not usually
found in these diseases. Hence, it is difficult to relate intra-tuft
Mf directly with Mf in tubular lumen or in urinary sediments.
However, by this alternative pathway we can explain such a
phenomenon simply as follows: some humoral mediator that is
contained in proteinuria passes through GBM and affects glomer-
ular or tubular epithelial cells, transforming them into macro-
phage-like cells that exfoliate into Bowman’s space and tubular
lumen. The results of double staining for CD68 and cytokeratin in
the present study does not support this possibility, but still it is
undeniable, since even if there was enough time for having both
markers simultaneously, it might be very short and difficult to
catch in limited human materials. Similar to Mf, tubular and
glomerular epithelial cells are known to express MHC-Class II
and have an antigen presenting ability [8, 31]. Moreover, trans-
formation of rat glomerular visceral epithelial cells into macroph-
agic cells has recently been reported [32]. Thus, it would not be
surprising for tubular or glomerular epithelial cells to change
phenotype to express Mf markers.
With respect to the pathophysiological roles of G-Mf in GN,
we suspect that there are two functions. First, they may participate
in the clearance of debris that would be produced at the inflamed
sites of glomeruli. Actually, SR are known to mediate the
monocyte/Mf’s uptake and degradation of chemically modified
proteins, such as acetylated and oxidized low-density lipoprotein
(LDL), maleylated albumin, and endotoxin [23, 25], and induce
them transform into lipid-laden Mf. Secondly, G-Mf may cause
tubular epithelial cell damage via adhesion through the ICAM-1-
LFA-1 pathway. Macrophages with such morphology and pheno-
types are known to develop a capacity for both antibody-depen-
dent and antibody-independent cellular cytotoxicity in vitro [11],
and tubular epithelial cell changes such as vacuole formation and
hyaline droplet degenerative changes are often found around sites
with attached G-Mf. These facts suggest a role of G-Mf in the
tubular damage of GN patients.
With respect to the laboratory examination of GN patients, a
major finding in the present study relates to the significant
correlations between intratubular G-Mf counts and urinary RBC
levels, serum creatinine values in total GN patients, and protein-
uria in IgAN patients. Moreover, this characteristic cell also
appeared in the urine. From these findings, we suggest that an
evaluation of urinary G-Mf levels might be worth testing, since it
may also be an indicator of GN activity and progression, and it is
a noninvasive, simple examination. These studies are currently in
progress in our laboratory.
We believe that careful attention to G-Mf in biopsy specimens
and in urine affords many opportunities for understanding the
activity and the progression of each GN, especially those with
crescents.
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